Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/22921
Title: Ustekinumab is a safe and effective biologic agent for Crohn's disease in a Liver Transplant patient.
Austin Authors: Peverelle, Matthew R ;Asadi, Khashayar;De Cruz, Peter P 
Affiliation: Department of Anatomical Pathology, Austin Health, Heidelberg, Victoria, Australia
Department of Gastroenterology, Austin Health, Heidelberg, Victoria, Australia
Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia
Issue Date: 31-Mar-2020
metadata.dc.date: 2020-03-31
Publication information: Journal of Crohn's & colitis 2020; online first: 31 March
URI: http://ahro.austin.org.au/austinjspui/handle/1/22921
DOI: 10.1093/ecco-jcc/jjaa062
ORCID: 0000-0003-0136-6699
0000-0002-3399-7236
PubMed URL: 32232397
Type: Journal Article
Subjects: Crohn’s disease
Liver transplantation
Ustekinumab
Appears in Collections:Journal articles

Show full item record

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.